Ilker Ozturk

Ilker Ozturk

Auto-generated profile, based on publicly available information

Ilker Ozturk

Department of Neurology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
AFASLIHAN FİDANCI
ASLIHAN FİDANCI
IÖİlKer Öztürk
İlKer Öztürk
AKAhmet Candan Köylüoğlu
Ahmet Candan Köylüoğlu
MYMehmet Yildiz
Mehmet Yildiz
ŞBŞencan Buturak
Şencan Buturak
ZAZülfikar Arlier
Zülfikar Arlier
Although ulnar neuropathy at the elbow (UNE) is the second most common entrapment mononeuropathy, there are few reports on its neurophysiological classification. In this study, we tried to find out the role of needle electromyography (EMG) in the neurophysiological classification of UNE. UNE patients who met the clinical and neurophysiological diagnostic criteria and healthy individuals were included in this study. Reference values of nerve conduction studies were obtained from healthy individuals. Needle EMG was performed to all UNE patients. According to the neurophysiological classification proposed by Padua, UNE patients were classified as mild, moderate and severe. Thirty-one controls and thirty-five UNE patients were included in the study. There was mild UNE in 23 patients, moderate UNE in 8, and severe UNE in 4. Abnormal needle EMG findings were present in all patients with moderate and severe UNE and in 12 patients with mild UNE. Abnormal needle EMG findings are seen in most of the UNE patients. Therefore, it is not practical to use needle EMG findings in the neurophysiological classification. Needle EMG abnormalities may also be present in patients with mild UNE due to axonal degeneration or motor conduction block.

1 April 2016 in Epilepsy & Behavior
Verified
Journal Article
Closed access
IÖİlker Öztürk
İlker Öztürk
KAKezban Aslan
Kezban Aslan
HBHacer Bozdemir
Hacer Bozdemir
NFNancy Foldvary-Schaefer
Nancy Foldvary-Schaefer

30 March 2022 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
TİTuğba Kurumoğlu İncekalan
Tuğba Kurumoğlu İncekalan
DTDerya Taktakoğlu
Derya Taktakoğlu
GŞGöksu Hande Naz Şimdivar
Göksu Hande Naz Şimdivar
IÖİlKer Öztürk
İlKer Öztürk

1 January 2021 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
AFASLIHAN FİDANCI
ASLIHAN FİDANCI
IÖİlKer Öztürk
İlKer Öztürk
Halit Fidancı and İlker Öztürk. Korean J Pain 2021;34:124-31. https://doi.org/10.3344/kjp.2021.34.1.124

1 August 2025 in Medicine
Verified
Journal Article
Open access
DODerya Ozdogru
Derya Ozdogru
AYAbdullah Yıldırım
Abdullah Yıldırım
GYGulcin Yenice
Gulcin Yenice
OUOnur kadir Uysal
Onur kadir Uysal
IOIlker Ozturk
Ilker Ozturk
ZAZulfikar Arlier
Zulfikar Arlier
Endovascular treatment (EVT) is the treatment method for acute ischemic stroke (AIS) caused by large vessel occlusion. Contrast-induced acute kidney injury (CI-AKI) is a relatively common complication. In this study, we aimed to investigate the incidence and possible risk factors of CI-AKI including systemic inflammation response index (SIRI) and systemic immune inflammation index (SII) in patients undergoing mechanical thrombectomy. We retrospectively analyzed patients who underwent EVT for acute cerebral large vessel occlusion between January 1, 2021, and March 31, 2024. Before the intervention, blood was drawn from the antecubital vein and collected in the appropriate tubes. Serum levels of neutrophils, lymphocytes, platelets, hemoglobin, CRP, and albumin were measured, alongside lipid profiles and liver and kidney function parameters. An increase in serum creatinine of 0.5 mg/dL or more than 25% in the measurements 48 to 72 hours after EVT compared to before was defined as CI-AKI. SII was calculated with the formula of: peripheral (platelet count × neutrophil count)/ lymphocyte count; SIRI was calculated with the formula of: (neutrophil count × monocyte count)/ lymphocyte count. Their predictive value for CI-AKI occurrence was compared. CI-AKI was detected in 54 (19%) of the 281 patients included in the study. In terms of clinical parameters, baseline NIHSS, postthrombectomy, cerebral edema, hemorrhagic transformation, recanalization time, discharge mRS and contrast amount were significantly higher in patients with CI-AKI. SII exhibited the highest discriminative performance in predicting CI-AKI in patients undergoing mechanical thrombectomy, with a threshold of > 1784 (AUC = 0.710, 95% CI: 0.631–0.788, P < .001, sensitivity 42.6%, specificity 89.0%) followed by SIRI (AUC = 0.652, 95% CI: 0.576–0.728, P < .001, sensitivity 88.9%, specificity 37.9%). SII and SIRI were found to be significantly higher in patients with CI-AKI. These scores may be new promising low-grade inflammatory indicators for predicting CI-AKI development.

27 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
OUOnur kadir Uysal
Onur kadir Uysal
DODerya Ozdogru
Derya Ozdogru
AYAbdullah Yıldırım
Abdullah Yıldırım
IOIlker Ozturk
Ilker Ozturk
GTGuluzar TRAS
Guluzar TRAS
ZAZulfikar Arlier
Zulfikar Arlier
Background/Objectives: The Naples prognostic score (NPS), reflecting inflammation and nutritional status, has prognostic value, especially in cancer. This study evaluated its ability to predict in-hospital mortality in acute ischemic stroke (AIS) patients undergoing endovascular treatment (EVT). Methods: We retrospectively studied 244 patients with AIS who were admitted between April 2020 and December 2023. Patients were included if they presented within 6 h of symptom onset with evidence of intracranial proximal arterial occlusion. The EVT was performed using aspiration catheters, stent retrievers, or both. The NPS was calculated based on the neutrophil–lymphocyte ratio, lymphocyte–monocyte ratio, and albumin and total cholesterol levels. Results: We found a significant association between higher NPS scores and in-hospital mortality. Patients with a high NPS (3 or 4) had a mortality rate of 41.6% compared to 21.0% in the low-NPS group (0, 1, or 2). The full model incorporating NPS showed superior predictive ability for in-hospital mortality compared with the baseline model (areas under the curve 0.881 vs. 0.808). A receiver-operating characteristic analysis at a cutoff of >2.5 for the NPS showed a sensitivity of 86.6% and specificity of 41.9%. This study demonstrated that incorporating the NPS into the predictive model improved the accuracy and calibration for predicting in-hospital mortality. A decision curve analysis showed the net benefit of using the full model incorporating NPS over the baseline model, emphasizing its potential clinical application in prognostication. Conclusions: NPS is a reliable predictor of in-hospital mortality in AIS patients undergoing EVT. Incorporating NPS into clinical practice could help to identify high-risk patients and improve outcomes through tailored interventions.